<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Eli Lilly and Co.; Withdrawal of Approval of a New Drug Application for ORAFLEX</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Eli Lilly and Co.; Withdrawal of Approval of a New Drug Application for ORAFLEX</h1>
    <p class="timestamp">Published: 2013-06-04 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is withdrawing approval of a new drug application (NDA) for ORAFLEX (benoxaprofen) Tablets, held by Eli Lilly and Co. (Lilly), Lilly Corporate Center, Indianapolis, IN 46285. Lilly has voluntarily requested that approval of this application be withdrawn, and has waived its opportunity for a hearing.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2013-13053</p>
    <p><strong>Publication Date:</strong> 2013-06-04</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2013/06/04/2013-13053/eli-lilly-and-co-withdrawal-of-approval-of-a-new-drug-application-for-oraflex">https://www.federalregister.gov/documents/2013/06/04/2013-13053/eli-lilly-and-co-withdrawal-of-approval-of-a-new-drug-application-for-oraflex</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2013-13053</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
